Applied DNA Sciences, Inc.
APDN
$0.1314
$0.00181.39%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 47.17% | 1.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 47.17% | 1.96% | |||
| Cost of Revenue | -9.80% | 2.88% | |||
| Gross Profit | 179.34% | -0.12% | |||
| SG&A Expenses | -1.91% | 0.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.87% | -1.44% | |||
| Operating Income | 9.39% | 2.25% | |||
| Income Before Tax | 19.46% | -279.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.46% | -279.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 72.35% | -43.89% | |||
| Net Income | 19.94% | -275.38% | |||
| EBIT | 9.39% | 2.25% | |||
| EBITDA | 9.04% | 0.57% | |||
| EPS Basic | -73.97% | -168.33% | |||
| Normalized Basic EPS | 73.92% | -167.48% | |||
| EPS Diluted | -73.97% | -168.33% | |||
| Normalized Diluted EPS | 73.92% | -167.48% | |||
| Average Basic Shares Outstanding | 205.96% | 156.63% | |||
| Average Diluted Shares Outstanding | 205.96% | 156.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
